Reuters logo
BRIEF-Integragen presents new data for its miR-31-3p biomarker at 2016 ESMO Congress
October 10, 2016 / 4:36 PM / a year ago

BRIEF-Integragen presents new data for its miR-31-3p biomarker at 2016 ESMO Congress

Oct 10 (Reuters) - Integragen SA :

* New data on Integragen’s mir-31-3p biomarker featured in presentation at 2016 ESMO Congress

* Data presented concludes that mir-31-3p expression is predictive of anti-EGFR therapy effect on objective response, depth of response, and early tumor shrinkage in patients with metastatic colorectal cancer enrolled in prospective, randomized FIRE-3 Trial Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below